Analytica Biosciences

Westport, United States Founded: 2023 • Age: 3 yrs
Offers an AI-based platform for genomics-driven drug discovery solutions.

About Analytica Biosciences

Analytica Biosciences is a Healthcare company based in Westport (United States) founded in 2023. It offers an AI-based platform for genomics-driven drug discovery solutions. It operates on a B2B model. Its focus areas include Biotechnology, Genomics, Drug Discovery and AI-Based Platforms. Its competitors include Seven Bridges Genomics, Ingenuity Systems and Envisagenics; 3 of its 3 listed competitors have raised funding.

Company details

Analytica Biosciences offers an ai-based platform for genomics-driven drug discovery solutions, focusing on advancing biotech innovations, focusing on genomic solutions, drug discovery, and ai-based platforms. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets.

  • Headquarters Westport, United States
  • Sectors
    Healthcare
  • Website analyticatx.com
  • Social X

Competitors of Analytica Biosciences

Analytica Biosciences has 3 listed competitors in our database, 3 of them funded. They include Seven Bridges Genomics, Ingenuity Systems and Envisagenics.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
sevenbridges.com2009Cambridge, United States$113M112
Cloud-based platform to analyze, store, and act on genomic data.
ingenuity.com1998Redwood, United States$20.4M30
Genomic data is analyzed and interpreted via web-based applications.
envisagenics.com2014Long Island, United States$46.78M
RNA splicing therapeutics are discovered and developed through AI-driven biotechnology.
Premium access

Detailed competitors of Analytica Biosciences

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Genomics & Gene Therapy Platforms

3 companies that operate in the same segment as Analytica Biosciences (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
mRNA-based therapeutics for diseases including cancer and infections are developed.
2010Cambridge, Massachusetts, United StatesUSD 2.78 BUSD 1.94 B5,800
Digital sequencing technology for cancer detection is developed.
2012Redwood City, California, United StatesUSD 557.5 MUSD 982.02 M4,867
Circulating tumor DNA is screened for early cancer detection.
2016Menlo Park, California, United StatesUSD 2 BUSD 147.17 M1,141
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Analytica Biosciences

Analytica Biosciences was founded in 2023.

Analytica Biosciences is headquartered in Westport, United States.

Analytica Biosciences offers an ai-based platform for genomics-driven drug discovery solutions, focusing on advancing biotech innovations, focusing on genomic solutions, drug discovery, and ai-based platforms. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets.

Analytica Biosciences's top competitors include Ingenuity Systems, Envisagenics and Seven Bridges Genomics.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available